See Downloads
See Downloads

Commitment

Merck aims to reduce its greenhouse gas emissions in order to mitigate the impact of the company on climate. What are the concrete plans? The company plans to reduce direct greenhouse gas emissions and emissions from purchased energy (Scope 1 and Scope 2) by 50% by 2030 – in comparison with 2020. Indirect emissions along the entire value chain (Scope 3) are to be reduced by 1,500 kilotons of carbon dioxide (or other greenhouse gases with the same climatic impact) by 2030. By 2040, Merck will be climate neutral.

Lighthouse initiative

Greener with wind energy
By signing a 12-year renewable energy contract in the United States, Merck achieved a milestone on its climate goal journey. The virtual power purchase agreement covers 68 megawatts. This corresponds to 65% of the total electricity consumption in the U.S., where the company´s energy requirements are the highest. The wind park is currently under construction in Texas with plans to achieve commercial operation in 2022.

Out with planes, in with ships
Global freight transport makes up around 10% of global CO2 emissions. Here companies can make a real difference: Merck aims to transport 90% of its Healthcare products by ship by 2023. Between 2019 and 2020, switching from air to sea freight helped the company to cut down CO2 emissions by 5,000 metric tons.

More information: https://www.merckgroup.com/en/sustainability/environment.html

Commitment

At Roche we reduced our greenhouse gas emissions by 62.7% absolute from 2009 – 2022 (own operations and purchased energies). We have set goals to further reduce emissions by another 75% from 2019 – 2029, to use 100% sustainable electricity by 2025 and to achieve real zero in 2050.

Lighthouse initiative

We recently extended our site in Kaiseraugst (Switzerland) with numerous new buildings, including our global IT centre, learning centre, quality labs etc.

This site is fully powered by sustainable electricity.

The buildings are highly energy-efficient and we built a wood chip heating plant using waste wood, geothermal cooling, and several solar power installations, including one of the biggest facade solar plants in Switzerland.

Commitment

In 2015, during the COP21 UN Climate Conference in Paris, Philips committed to become carbon neutral in its operations (i.e. its industrial and non-industrial sites, business travel and logistics) by the end of 2020.
Next, in 2021, Philips committed to long term CO2 reduction targets reducing total CO2 equivalent (tCO2e) emissions from its industrial and non-industrial sites by 75% by 2025, and 90% by 2040, compared to their 2015 emissions, together with a commitment to reducing indirect greenhouse gas emissions across its entire value chain by 4% by 2025, and 11% by 2040, compared to 2017.
As a health technology industry-first, Philips has had its CO2 emission targets assessed and approved by the Science Based Targets initiative (SBTi) – a collaboration between the CDP, the United Nations Global Compact (UNGC), the World Resources Institute (WRI) and the World Wide Fund for Nature (WWF) aimed at driving ambitious corporate climate action.

Lighthouse initiative

Philips confirmed it had delivered on its carbon neutral ambition at the beginning of 2021. It has developed a programme that links to its full value chain, ranging from EcoDesign to energy-efficiency improvement measures especially in the use phase of products, on-site renewables, green electricity sourcing to green logistics. One lighthouse project that Philips worked on related to the sourcing of green electricity through so-called Power Purchase Agreements. Together with DSM, Google and Nouryon (formerly AkzoNobel Specialty Chemicals) it founded the Dutch Wind Consortium. Subsequently, the Consortium closed two Power Purchase Agreements in the Netherlands, with the Krammer and Bouwdokken windfarms in the Zeeland province. A case study on this unique consortium has been written by the Business Renewable Centre and the Rocky Mountain Institute.

In addition, Philips, Heineken, Nouryon and Signify formed the first consortium to sign a Pan-European green energy deal in 2020, securing additional renewable electricity for Europe. The four companies have a shared vision to further reduce CO2 emissions in support of the UN Paris Agreement and the European Green Deal objectives. The companies joined forces to support the development of 35 wind turbines in the Mutkalampi municipality in Finland, which is scheduled for completion in 2023. As part of the consortium, Philips secures renewable electricity supply to power its European operations for a 10-year period.

Adding green energy to the grid: Philips forms first Pan-European consortium for future wind farm

Commitment

Launched at the World Economic Forum in January 2020, ‘Ambition Zero Carbon’ is AstraZeneca’s commitment to reduce greenhouse gas emissions from its global operations and fleet (Scope 1 and 2) by 98% by 2026, and halve its entire value chain footprint by 2030 on the way to a 90% reduction by 2045. By 2030, the company will go even further to become carbon negative for all residual emissions.

In meeting these targets, by 2025 AstraZeneca will double its energy productivity; use 100% renewable energy for power and heat, eliminate F-Gas emissions from its sites, transition to next-generation respiratory inhalers with near-zero climate impact propellants and plant and maintain 50 million trees under its ‘AZ Forest’ programme. AstraZeneca was the first pharmaceutical company to be a member of all three of the Climate Group’s RE100, EV100 and EP100 initiatives.

The company’s Scope 1, 2 and 3 greenhouse gas emission reduction targets have been verified by the Science-Based Targets Initiative as being consistent with reductions required to keep warming to 1.5°C, the most ambitious goal of the Paris Agreement.

Lighthouse initiative

‘AZ Forest’ – Alongside the work to eliminate carbon emissions from its operations and value chain, AstraZeneca recognises the direct link between reforestation and the impact it can have on both the climate and human health. Trees naturally remove CO2 and are essential to mitigate the effects of climate change. ‘AZ Forest’ is a reforestation initiative where 50 million trees will be planted and maintained by the end of 2025, with longer term stewardship to ensure their permanence. By the end of 2021, working with local governments and NGOs such as One Tree Planted, AstraZeneca had planted 3.4 million trees in Australia, Indonesia, Ghana, the UK and France. By the end of 2022, the company aims to have planted over eight million trees, and overall, will be collaborating with over 40,000 farmers around the world to help build ecological and community resilience.